Stockwinners Market Radar for January 29, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:33 EDT M.D.C. Holdings declares special 8% dividend on common stock - M.D.C. Holdings announced that on January 28, 2019 its board of directors maintained its regular cash dividend of 30c per share as well as a special 8% stock dividend on the company's common stock. The cash dividend will be paid on Wednesday, February 27, 2019 to shareholders of record on Wednesday, February 13, 2019.

18:46 EDT S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices - S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Monday, February 4: Caesars Entertainment (CZR) will replace Dril-Quip (DRQ) in the S&P MidCap 400 and Dril-Quip will replace Essendant (ESND) in the S&P SmallCap 600. Staples is acquiring Essendant in a deal expected to close soon pending final conditions. Conn's (CONN) will replace Electro Scientific Industries (ESIO) in the S&P SmallCap 600. MKS Instruments (MKSI) is acquiring Electro Scientific Industries in a deal expected to close on February 1 pending final approvals. On a date to be announced, Walt Disney (DIS) is to acquire Twenty-First Century Fox (FOXA, FOX) one day after Twenty-First Century Fox completes a spin-off of a portfolio of its news, sports and broadcast businesses. For index purposes, post the spin-off and merger transactions, "new" Fox, to be called Fox Corp., will be considered the surviving entity of Twenty-First Century Fox and will continue to be included in the S&P 500. An S&P 500 constituent to be named later will replace "new" Fox in the S&P 100 on a date to be announced.

18:22 EDT Nucor CEO: 'Our customers are doing very well' - In an interview on CNBC's Mad Money, Nucor CEO John Ferriola said: 'Our customers are doing very well... 23 of 24 downstream business we sell into will remain steady in 2019... Tariffs imposed in March helped increase shipments compared to a year ago... Tariffs give us confidence to make investments...Given what has happened with the tariffs, we are now confident we can compete successfully."

18:05 EDT Silicon Motion sees FY19 non-GAAP revenue to be similar to FY18 - Sees FY19 Gross Margin and Operating Margin to be approximately similar to the prior year if product mix remains unchanged.

17:42 EDT Aslan Pharmaceuticals announces strategic corporate restructuring - ASLAN Pharmaceuticals announced a strategic corporate restructuring to focus its resources on its lead clinical programs: varlitinib in biliary tract cancer, ASLAN003 in acute myeloid leukaemia and ASLAN004 in atopic dermatitis. ASLAN will focus its resources on the late-stage development of varlitinib as a potential novel treatment for first- and second-line BTC. Enrolment in a global pivotal study of varlitinib in second-line BTC, the TreeTopp study, was completed ahead of schedule in December 2018 and topline data is expected in the second half of 2019. ASLAN will be closing the ongoing single-arm second-line BTC study in China as it is now expected to read out after the TreeTopp study. If positive, data from the TreeTopp study will be used to submit a New Drug Application in China, the US and other major geographies. ASLAN recently reported positive phase 1b results from an ongoing study of varlitinib as a first-line treatment for BTC which demonstrated that varlitinib increased objective response rate compared to standard of care and this study will continue to recruit patients to strengthen this dataset. The clinical development of ASLAN003 in AML and ASLAN004 in atopic dermatitis remains on track. ASLAN expects to complete the first part of the phase 2 study of ASLAN003 in AML and the phase 1 SAD study of ASLAN004 in the first half of 2019. Following this strategic review, ASLAN will reduce its cost base, including a reduction in headcount by 30%. In total, the planned changes will lower operational costs by 50%. ASLAN does not expect to incur any material restructuring charges. In addition to the reduction in headcount, Dr Bertil Lindmark, currently Chief Medical Officer, has announced he will retire and return to Europe. Dr Chih-Yi Hsieh, currently VP Medical and GM Taiwan, will assume the role of acting Chief Medical Officer. Dr Mark McHale, COO, will transition to the role of Chief Development Officer and Head of R&D with immediate effect.

17:30 EDT BlackRock CEO Fink sells over 5,000 common shares - In a regulatory filing, BlackRock chairman and CEO Laurence Fink disclosed the sale of 5,120 common shares of the company in two transactions. The first transaction of 3,970 shares was sold at $412.59 per share, while the second transaction of 1,150 shares was sold at $413.36 per share.

17:30 EDT Russell Investments reports 10.5% passive stake in Orion Group - Russell Investments' stake in Orion Group represents 10.5% or 3,045,714 shares. The stake does not allow for activism.

17:28 EDT Conn's to replace Electro Scientific in S&P 600 at open on 2/4 - MKS Instruments (MKSI) is acquiring Electro Scientific Industries (ESIO) in a deal expected to close on February 1 pending final approvals.

17:25 EDT Caesars to replace Dril-Quip in S&P 400 at open on 2/4

17:20 EDT Russell Investments reports 8.4% passive stake in NeoPhotonics - In a regulatory filing, Russell Investments disclosed an 8.4% stake in NeoPhotonics, which represents about 3.86M shares. The filing does not allow for activism.

17:17 EDT Helmerich & Payne cuts FY19 CapEx view to $500M-$530M from $650M-$680M - Vice President and CFO Mark Smith commented, "This recent lack of clear direction in crude prices is injecting an amount of uncertainty into some of our customers' drilling plans for 2019. H&P, like our customers, has responded accordingly. H&P is slowing the cadence of super-spec upgrades creating a commensurate reduction in our planned capital expenditures for the year. We have reduced our budgeted capex by over 20%, approximately $150M from our initial budget. As in the past with volatile markets, the company will maintain a disciplined capital allocation strategy and we remain confident that our operational results and financial strength will support that strategy."

17:14 EDT K12 Chairman Nathaniel Davis sells almost $3M in company stock - K12 Chairman Nathaniel Davis disclosed in a filing that he had sold 100,000 shares of company stock at an average price of $29.06 per share on January 25 . The total transaction value was $2,906,000.

17:07 EDT Parker-Hannifin appoints Jennifer Parmentier VP and President Motion Systems - Parker Hannifin announced that Jennifer A. Parmentier, currently Vice President and President - Engineered Materials Group, has been appointed Vice President and President - Motion Systems Group. The company also announced that current Vice President and President - Motion Systems Group, Andrew M. Weeks has been appointed Vice President and President - Engineered Materials Group. These leadership changes are effective February 1, 2019."Jenny and Andy have created a culture focused on safety and providing a premier customer experience, and enjoyed great success delivering profitable growth and strong financial performance in their current roles," said Lee Banks, President and Chief Operating Officer. "This change in roles will provide them valuable exposure to different areas of the business. We anticipate a smooth transition of responsibilities and are fortunate to have such depth of talent at the executive level." Ms. Parmentier has held the position of Vice President and President - Engineered Materials Group since September 2015. She joined Parker in 2008 as Plant Manager for the Sporlan Division, part of the Instrumentation Group, and went on to become Business Unit Manager and then General Manager of the Division. Prior to her current role, she served as General Manager for the Hose Products Division in the Fluid Connectors Group, Parker's largest industrial division. Mr. Weeks was named Vice President and President - Hydraulics Group in September 2015 and became Vice President and President - Motion Systems Group in 2017, when the Hydraulics Group merged with the Pneumatics and Electromechanical businesses of the Automation Group. Mr. Weeks joined Parker in 2013 as Vice President of Operations for the Aerospace Group.

17:05 EDT Modine Manufacturing exploring strategic alternatives for automotive business - Modine Manufacturing announced that it is exploring strategic alternatives for its automotive business. Modine's Vehicular Thermal Solutions, or VTS, portfolio currently serves three market segments; automotive, commercial Vehicle and off-highway. Within that portfolio, as well as compared to the rest of Modine's segments, the automotive market has different industry dynamics, growth trajectories, and strategic opportunities that require a deeper evaluation on how best to allocate capital and resources to optimize returns and strengthen Modine's leading positions in the markets it serves. Modine's automotive business is involved in in thermal management solutions for engine and powertrain cooling. In addition, this business is well positioned to solve complex cooling problems for battery thermal management and the increasing electrification requirements of next generation drivetrains. Modine's automotive business accounts for approximately 25% of total company revenue. Modine expects to complete its assessment of strategic alternatives over the next several quarters and will provide more information when it determines further disclosure is appropriate or required. There can be no assurances that any actions will be taken in response to this assessment, and any final decision remains subject to approval by Modine's board. "Today's announcement reinforces our strategic priority to continue to grow our global, market leading positions in Commercial HVAC, Refrigeration, Commercial Vehicle, and Off-Highway market segments, both organically and inorganically," CEO Tom Burke said. "Building upon the momentum from our significant acquisition in 2016, which created our Commercial & Industrial Solutions (CIS) division, Modine has become and will continue to be a more diversified industrial, thermal management company with higher margins, improved cash generation and lower capital intensity."

16:57 EDT Juniper down 7.9% or $2.21 at $25.74 after guiding FY19 below consensus

16:55 EDT UMB Financial trading halted, news pending

16:51 EDT Newcrest Mining reports Q2 gold output 655K oz, up 19% from Q1 - Q2 copper output 27KT, up 8% from Q1. Sees FY19 gold output 2.35M-2.60M oz.

16:49 EDT Ontario Teachers Pension Plan takes 5.62% passive stake in TrueCar - Ontario Teachers Pension Plan disclosed a 5.62% passive stake in TrueCar. The stake represents 5.85M shares. The filing with the SEC does not allow for activism.

16:36 EDT Apple jumps 3%, or $4.50, to $159.18 after fiscal Q1 results

16:34 EDT Apple net cash at $130B, continues to target 'neutral position over time' - Apple CFO Luca Maestri said in tonight's earnings release, "We generated very strong operating cash flow of $26.7 billion during the December quarter and set an all-time EPS record of $4.18. We returned over $13 billion to our investors during the quarter through dividends and share repurchases. Our net cash balance was $130 billion at the end of the quarter, and we continue to target a net cash neutral position over time."

16:33 EDT Google Customer Solutions President Mary Ellen Coe to join Merck board - Merck (MRK) announced that Mary Ellen Coe, president, Google Customer Solutions, at Google Inc (GOOGL) will join the company's Board of Directors effective March 18, 2019. Ms. Coe will stand for election with the company's other directors in connection with Merck's Annual Meeting of Shareholders on May 28, 2019. With the addition of Ms. Coe, the Merck board will include 13 members.

16:32 EDT Apple reports Q1 iPhone revenue down 15% from last year - Apple said revenue from iPhone declined 15% from the prior year in fiscal Q1, while total revenue from all other products and services grew 19%. Services revenue reached an all-time high of $10.9B, up 19% over the prior year, in the quarter. Revenue from Mac and Wearables, Home and Accessories also reached all-time highs, growing 9% and 33%, respectively, and revenue from iPad grew 17%.

16:32 EDT TechnipFMC awarded 'substantial' integrated EPCI contract - TechnipFMC has been awarded a "substantial" integrated Engineering, Procurement, Construction and Installation contract from Lundin Norway for the Luno II and Rolvsnes development, located in the North Sea at a water depth of 110 meters. The contract covers the delivery and installation of subsea equipment including umbilicals, rigid flowlines, flexible jumpers and subsea production systems. For TechnipFMC, a "substantial" contract ranges between $250M and $500M.

16:31 EDT B&G Foods CEO Bob Cantwell to retire in April - B&G Foods announced that Robert C. Cantwell, the company's Chief Executive Officer has notified the board of directors that he plans to retire on April 5, 2019. Cantwell's retirement will bring to a close a career that includes approximately 23 years of leadership as Executive Vice President of Finance and Chief Financial Officer and more than four years of leadership as President and Chief Executive Officer. Following his retirement, it is expected that Cantwell, who turns 62 later this week, will continue to advise the company on M&A and capital markets transactions.

16:27 EDT AMD jumps almost 3% after quarterly report, guidance - Shares are up approximately 3% to $19.92 per share in after-market trading.

16:25 EDT Broadfin Capital reports 5.57% passive stake in Aclaris Therapeutics - In a regulatory filing, Broadfin Capital disclosed a 5.57% stake in Aclaris, which represents 2.28M shares. The filing does not allow for activism.

16:22 EDT eBay reports Q4 active buyers up 4% to 179M globally - In the fourth quarter, eBay grew active buyers by 4% across its platforms, for a total of 179M global active buyers. Underlying total eBay performance, the Marketplace platforms delivered $2.3B of revenue and $23.2B of GMV. Marketplace revenue growth was 7% on an as-reported basis and 6% on a FX-Neutral basis, and GMV was up 1% on an as-reported basis and 3% on a FX-Neutral basis. StubHub drove revenue of $314M, up 2% on both an as-reported and FX-Neutral basis, and GMV of $1.4B, down 2% on an as-reported basis and down 1% on a FX-Neutral basis. Classifieds platforms delivered revenue of $263M, up 8% on an as-reported basis and 11% on a FX-Neutral basis.

16:20 EDT eBay announces changes to capital structure - In order to evolve eBay's capital structure given its strong cash generation profile and shareholder return objectives, the company announced: Initiation of a quarterly dividend of 14c per share, with the first quarterly dividend to be paid on or about March 20 to shareholders of record as of the close of business on March 1. Expect to exit 2019 with cash and investments of approximately $3.5B. Targeting mid-term leverage of approximately 1.5x net debt and gross debt below 3.0x EBITDA. Increase in share repurchase authorization by an additional $4B with no expiration, with an expected 2019 share repurchase of approximately $5B. Expect to return approximately $7B to shareholders through dividends and repurchases over the next two years, with approximately $5.5B in 2019 and approximately $1.5B in 2020.

16:19 EDT Inspire Medical announces FDA approval of sensing lead - Inspire Medical Systems announced that the FDA has approved for use in the U.S. Inspire's new sensing lead. Inspire intends to introduce the new sensing lead to its U.S. medical center customers in March 2019.

16:17 EDT First Horizon increases quarterly dividend 17% - The board approved payment of a quarterly cash dividend on First Horizon's common stock of 14c per share, an increase of 17% from 2018. The common dividend is payable on April 1 to the common shareholders of record on March 15.

16:16 EDT eBay initiates 14c per share dividend, expands share repurchase by $4B

16:12 EDT Reports Q4 net premiums written $1.52B vs. $1.48B last year - Reports Q4 combined ratio 95.9% vs. 94.9% last year.

16:10 EDT Tandy Leather to close three stores - As part of an ongoing evaluation of its store portfolio, Tandy Leather has made the strategic decision to close three underperforming stores located in Irving, Texas; Fort Wayne, Indiana; and Minto, Australia. The Irving and Fort Wayne locations closed last week, while the Minto store will be closed next month.

16:09 EDT MicroStrategy adopts Accounting Standards Update, adjust prior statements - MicroStrategy said it adopted Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers and its subsequent amendments, effective January 1, 2018, and that it has adjusted its prior period consolidated financial statements to reflect full retrospective adoption.

16:08 EDT Amgen reports Enbrel sales down 8% in Q4 - Enbrel sales decreased 8% for the fourth quarter and the full year driven by lower unit demand and lower net selling price. NEUPOGEN sales decreased 40% for the fourth quarter driven by lower net selling price and lower unit demand. Sales decreased 34% for the full year driven by lower unit demand and lower net selling price.

16:07 EDT MicroStrategy falls 10% to $124.50 after Q4 miss, material weakness

16:07 EDT Pandora shareholders approve Sirius XM transaction - Pandora Media (P) announced that at a special meeting held earlier today stockholders of Pandora approved the acquisition of Pandora by Sirius XM Holdings Inc. (SIRI). At the special meeting of Pandora stockholders, holders of approximately 75% of the outstanding voting power of Pandora voting securities were voted, with approximately 97% of the votes cast in favor of the transaction. The transaction is expected to close shortly, subject to customary closing conditions. Assuming completion of the transaction, shares of Pandora common stock are expected to be delisted from trading on the New York Stock Exchange. As a result of the transaction, among other things, each share of Pandora common stock will be converted into 1.44 newly issued shares of Sirius XM common stock. Sirius XM common stock will continue to trade under the existing ticker symbol "SIRI" on The Nasdaq Global Select Market. As of the transaction close, Roger Lynch, Chief Executive Officer of Pandora, will be stepping down from his role and exiting the company. Jim Meyer, Chief Executive Officer of Sirius XM, will lead Pandora and Sirius XM as a combined company. Steve Bene, General Counsel of Pandora; Naveen Chopra, Chief Financial Officer of Pandora; and Kristen Robinson, Chief Human Resources Officer of Pandora, also will be exiting the company following the transaction closing.

16:06 EDT MicroStrategy expects to report material weakness in internal control - The company said in its earnings release, "MicroStrategy expects to report a material weakness in its internal control over financial reporting as of December 31, 2018 in its upcoming Annual Report on Form 10-K for the year ended December 31, 2018. The material weakness relates to general information technology controls in the areas of user access, program change-management and other matters impacting information technology systems that support MicroStrategy's financial reporting processes. There have been no misstatements identified in the financial statements as a result of this material weakness and MicroStrategy expects to timely file its Form 10-K. Remediation of this material weakness is expected to be completed prior to the end of fiscal year 2019." :theflyonthe

16:06 EDT MicroStrategy expects to report material weakness in internal control - The company in its earnings release, "MicroStrategy expects to report a material weakness in its internal control over financial reporting as of December 31, 2018 in its upcoming Annual Report on Form 10-K for the year ended December 31, 2018. The material weakness relates to general information technology controls in the areas of user access, program change-management and other matters impacting information technology systems that support MicroStrategy's financial reporting processes. There have been no misstatements identified in the financial statements as a result of this material weakness and MicroStrategy expects to timely file its Form 10-K. Remediation of this material weakness is expected to be completed prior to the end of fiscal year 2019."

16:04 EDT Hawaiian Holdings sees FY19 ASMs up 1.5%-4.5% vs last year - Sees FY19 cost per ASM excluding fuel flat to up 3.0% compared to last year.

16:03 EDT Hawaiian Holdings sees Q1 ASMs up 1.5%-3.0% - Sees Cost per ASM excluding fuel up 1.0%-4.0%.

16:01 EDT Nexa Resources announces resignation of CFO Mario Bertoncin - Nexa Resources announced that its board has approved the appointment of Rodrigo Menck to succeed Mario Bertoncini as Nexa's Senior Vice-President of Finance and CFO starting March 1st, 2019. Mr. Bertoncini is leaving the company to assume a new leadership role at CESP - Companhia Energetica de Sao Paulo, a publicly traded Brazilian power generation company whose major shareholder is a joint venture between Votorantim Energia and the Canada Pension Plan Investment Board. Mr. Bertoncini has served as Senior Vice President of Finance and CFO since 2014.

15:46 EDT FDA approves Janssen Biotech's sBLA for Tremfya - Reference Link

15:03 EDT Prana treatment of multiple system atrophy granted orphan designation - Prana Biotechnology's treatment of multiple system atrophy was granted orphan designation by the FDA, according to a post to the agency's website. Reference Link

14:27 EDT MGM Resorts, MGM Growth announce completion of Empire City transaction - MGM Resorts (MGM) and MGM Growth Properties (MGP) announced that they have completed the transactions for the acquisition of Empire City Casino in Yonkers, New York. Following MGM Resorts' acquisition of Empire City for approximately $850M, MGP acquired the developed real property from MGM Resorts for approximately $625M and leased it back to a subsidiary of MGM Resorts that will operate the property. MGM Resorts has also agreed to pay an additional $50M if Empire City is awarded a license for live table games on or prior to December 31, 2022 and MGM Resorts accepts such license by December 31, 2024. In addition, MGM Resorts has agreed to give MGP a right of first offer with respect to certain undeveloped land adjacent to the property to the extent MGM Resorts develops additional gaming offerings and chooses to sell or transfer the property in the future. Empire City was added to the existing Master Lease between MGM Resorts and MGP, and the initial rent payment to MGP increased by $50M. Consistent with the Master Lease terms, 90% of the increased rent will be contractually fixed to grow at two percent per year until 2022, and thereafter will continue to grow provided a tenant revenue to rent ratio is met. The remaining 10% is payable in percentage rent.

14:04 EDT Correction: Gildan Activewear reiterated as best idea long at Hedgeye

13:42 EDT Arlington Capital to acquire Triumph Group's forming, fabrication facilities - Arlington Capital Partners announced the signing of a definitive agreement for the carve-out acquisition of Triumph Group forming and fabrication facilities. With five locations in Hot Springs, AR; Fort Worth, TX; Shelbyville, IN; Phoenix, AZ; and San Diego, CA, the Company has a complex and differentiated capability set, operating in the forming, special processing and bonding markets, among others. The Company has many longstanding and strong relationships with blue-chip aerospace OEM and Tier 1 customers and has a diversified product portfolio across various aerospace platforms and end-markets.

13:02 EDT Exxon Mobil to proceed with new crude Unit as part of Beaumont expansion - ExxonMobil said that it has reached a final investment decision and started construction on a new unit at its Beaumont, Texas refinery that will increase crude refining capacity by more than 65 percent, or 250,000 barrels per day. The third crude unit within the facility's existing footprint will expand light crude oil refining, supported by the increased crude oil production in the Permian Basin. "With access to terminals, railways, pipelines and waterways nearby, the Beaumont refinery is strategically positioned to benefit from Permian production growth," said Bryan Milton, president of ExxonMobil Fuels and Lubricants Company. "The addition of a third crude unit in Beaumont will enhance the refinery's competitive position and truly establish it as a leader in the U.S. refining industry." Startup of the new unit is anticipated by 2022. The project is expected to create up to 1,850 jobs during construction and between 40 and 60 permanent jobs once completed. ExxonMobil previously announced plans to build and expand manufacturing facilities in the U.S. Gulf region as part of its Growing the Gulf initiative. Growing the Gulf projects include expansion of Beaumont's polyethylene capacity by 65 percent, a new unit in Beaumont that increases production of ultra-low sulfur fuels, and a new 1.5 million ton-per-year ethane cracker at the company's integrated Baytown chemical and refining complex in Texas. ExxonMobil and SABIC have also created a new joint venture to advance development of the Gulf Coast Growth Ventures project, a 1.8 million metric ton ethane cracker currently planned for construction in San Patricio County, Texas.

12:04 EDT TransDigm shares higher by 6.3% after reporting preliminary Q1 results - Shares of TransDigm are higher by 6.3% to $372.88 after the company released selected preliminary Q1 results in a filing before the market opened, including preliminary Q1 revenue of $993M against a consensus of $952.63M.

12:02 EDT EU says Google, Facebook, Twitter must do more against fake news - The European Commission published the first reports submitted by signatories of the Code of Practice against disinformation signed in October 2018. While the Commission welcomes the progress made, it also calls on signatories to intensify their efforts in the run up to the 2019 EU elections."Today, Google (GOOG, GOOGL), Facebook (FB), Twitter (TWTR), Mozilla and the trade associations representing the advertising sector have submitted their first reports on the measures they are taking to comply with the Code of Practice on Disinformation. There has been some progress, notably in removing fake accounts and limiting the visibility of sites that promote disinformation. However, additional action is needed to ensure full transparency of political ads by the start of the campaign for the European elections in all EU Member States, to allow appropriate access to platforms' data for research purposes, and to ensure proper cooperation between the platforms and individual Member States through contact points in the Rapid Alert System. According to the reports which cover measures taken by 31 December 2018, online companies' work is more advanced and comprehensive in some areas, for instance in taking down fake accounts and de-monetising the purveyors of disinformation, but less so in others. For the upcoming reports, the Commission expects Google, Facebook, Twitter and Mozilla to develop a more systematic approach to enable a proper and regular monitoring and assessment, on the basis of appropriate performance data."

12:01 EDT EU says Google, Facebook, Twitter must do more against fake news - The European Commission published the first reports submitted by signatories of the Code of Practice against disinformation signed in October 2018. While the Commission welcomes the progress made, it also calls on signatories to intensify their efforts in the run up to the 2019 EU elections."Today, Google, Facebook, Twitter, Mozilla and the trade associations representing the advertising sector have submitted their first reports on the measures they are taking to comply with the Code of Practice on Disinformation. There has been some progress, notably in removing fake accounts and limiting the visibility of sites that promote disinformation. However, additional action is needed to ensure full transparency of political ads by the start of the campaign for the European elections in all EU Member States, to allow appropriate access to platforms' data for research purposes, and to ensure proper cooperation between the platforms and individual Member States through contact points in the Rapid Alert System. According to the reports which cover measures taken by 31 December 2018, online companies' work is more advanced and comprehensive in some areas, for instance in taking down fake accounts and de-monetising the purveyors of disinformation, but less so in others. For the upcoming reports, the Commission expects Google, Facebook, Twitter and Mozilla to develop a more systematic approach to enable a proper and regular monitoring and assessment, on the basis of appropriate performance data."

12:00 EDT Brinker falls -11.3% - Brinker is down -11.3%, or -$5.36 to $42.08.

12:00 EDT Corning rises 9.6% - Corning is up 9.6%, or $2.91 to $33.27.

12:00 EDT PG&E rises 15.8% - PG&E is up 15.8%, or $1.90 to $13.91.

11:53 EDT Bion files for international patent on process to remediate livestock waste - Bion Environmental Technologies announced it has filed an application under the Patent Cooperation Treaty for international recognition of its process to produce a quick-release organic nitrogen fertilizer from livestock waste. The PCT application allows Bion to file patent applications and seek protection in most major market countries throughout the world. The U.S. Patent Office issued Patent No. 10,106,447 B2 on October 23, 2018, the first patent issued on Bion's third-generation technology. It describes a process to recover stable concentrated ammonium bicarbonate from the volatile ammonia in the livestock waste stream, using gas separation, condensation, filtration and crystallization under controlled operating temperatures, and without the addition of chemicals.

11:52 EDT LVMH to propose 20% dividend increase at annual meeting - LVMH will propose at its annual meeting on April 18 a dividend of EUR 6 per share, an increase of 20%. An interim dividend of EUR 2 per share was paid on December 6 of last year. The balance of EUR 4 per share will be paid on April 29, 2019.

11:49 EDT Lockheed Martin sees Saudi Arabia THAAD order bolstering 2019 sales - Sees getting two orders for Orion space capsule in Q2.

11:41 EDT Lockheed Martin doesn't see F-15 order by Pentagon reducing F-35 sales

11:34 EDT Lockheed Martin sees F-35 'block buy' covering 475-480 fighters - Sees F-35 output growing up to 160+ aircraft by 2021.

11:12 EDT Lockheed Martin says F-35 backlog has grown to nearly 400 fighters - Says new orders would extend F-16 production through mid-2020s. Sees FY20 presidential budget focused on missiles, nukes, space. Says hopeful FY20 will be in line with or better than prior presidential budget requests. Says might feel impact if U.S. budget stalemate continues. Comments taken from Q4 earnings conference call.

11:06 EDT Raytheon awarded $15.15M contract modification - Raytheon - Integrated Defense System has been awarded a $15.15M modification to a previously awarded contract for the Qatar Air and Missile Defense Operation Center. This modification provides for the procurement of the Qatar Alternate ADOC Prime Mission Equipment and software. This modification involves 100% foreign military sales to Qatar. Air Force Life Cycle Management Center, Hanscom Air Force Base, Massachusetts, is the contracting activity.

10:23 EDT Starbucks CEO says company doesn't get involved in national political campaigns - In a letter to employees made public by the company, Starbucks CEO Kevin Johnson stated in part: "Howard [Schultz] has moved forward to the next chapter of his life, where he has expressed an interest in public service, and potentially public office. Whatever he decides, it is my personal belief that Howard will continue to make a positive impact on the lives he touches, and I wish him well. Many of us will inevitably be asked if the company supports a possible presidential candidacy of Howard and what changes for Starbucks. As a company, we don't get involved in national political campaigns. And nothing changes for Starbucks. As we have for the past 48 years since Starbucks was founded, we will continue to live Our Mission and Values and create a great Starbucks customer experience in each of our stores...As we have always done, we remind you - that each of us, as citizens - has an opportunity to make our own informed decisions about politics and the future of our communities and our country. And as Starbucks partners, we have a responsibility to always recognize and respect the diversity of perspectives of all customers and partners on these topics." Reference Link

10:00 EDT Brinker falls -8.2% - Brinker is down -8.2%, or -$3.87 to $43.57.

10:00 EDT Centrais Electricas rises 11.0% - Centrais Electricas is up 11.0%, or $1.00 to $10.10.

10:00 EDT 3D Systems rises 14.5% - 3D Systems is up 14.5%, or $1.67 to $13.21.

09:49 EDT Osmotica Pharmaceuticals PLC trading halted, volatility trading pause

09:47 EDT Huya falls -7.4% - Huya is down -7.4%, or -$1.54 to $19.41.

09:47 EDT 3D Systems rises 9.1% - 3D Systems is up 9.1%, or $1.05 to $12.59.

09:47 EDT Meritor rises 11.5% - Meritor is up 11.5%, or $2.19 to $21.11.

09:41 EDT Harley-Davidson sees Q1 shipment down 7%-19% - Sees lower inventories in the U.S. coming out of Q1. Management sees retail sales to improve during the year. The company is investing heavily in new roads and better dealers. The company has gained momentum from 2017/2018 and expects that momentum to continue into 2019.

09:33 EDT Harley-Davidson sees Q1 shipments of 53,000-58,000 motorcycles

09:31 EDT Harley-Davidson intends to mitigate impact from EU, China tariffs by year-end - Sees SG&A lower in FY19.

09:23 EDT Harley-Davidson says recalls will not have 'material impact' to FY results - Comments provided during Q4 earnings conference call.

09:20 EDT Allergan says doesn't see net drug price growth in 2019

09:07 EDT Inspired Entertainment subsidiary extends contract with bet365 - Inspired Entertainment announced that its subsidiary Inspired Gaming has signed a multi-year extension to provide its scheduled Virtual Sports online to bet365, the world's largest online sports betting company with over 35 million customers worldwide. This new contract includes the provision of four additional streams of Virtual Sports content on bet365's interactive platform and a roadmap of new content for 2019.

09:05 EDT Arthur J. Gallagher acquires The Chapman Group - Arthur J. Gallagher & Co. announced the acquisition of Baton Rouge, Louisiana-based The Chapman Group. Terms of the transaction were not disclosed. Founded in 2003, The Chapman Group, Inc. is an employee benefit consultant and retail property/casualty broker offering coverage and services to clients throughout the state of Louisiana.

09:03 EDT NetEase acquires minority stake in Quantic Dream - NetEase Games announced that it has acquired a minority stake in Quantic Dream S.A. to further the development and distribution of global online games. Quantic Dream will continue to operate independently under the direction of industry veterans David Cage and Guillaume de Fondaumiere. Quantic Dream defines and leads the interactive storytelling game, a creative game genre. With 22 years of experience, this AAA studio has successfully launched several worldwide blockbusters, including Heavy Rain and Detroit: Become Human. This strategic investment aims to support the studio's vision of becoming a global, multi-franchise entertainment company, and to develop advanced technologies and games for the future.

08:53 EDT Verizon says voluntary separation program 'remains on track' - Says: Balance sheet now stronger... Expects excess cash flow to be deployed toward balance sheet goals in 2019... Employee pension 91% funded vs. 70% in 2016... Expects legacy products revenue to decline at "similar rate" in 2019 vs. 2018.

08:46 EDT Itron, ComEd to modernize municipal lighting in northern Illinois - Itron and ComEd, which delivers energy to more than 4 million customers in Chicago and northern Illinois, announced an initiative to modernize municipal lighting and drive smart city development in northern Illinois. Itron will connect and manage up to 140,000 municipal smart streetlights across ComEd's service territory, leveraging Itron's multi-application IPv6 networking platform that ComEd is using for a variety of smart grid applications. The smart streetlights will be managed using Itron's Streetlight.Vision Central Management System through a Software-as-a-Service model. This announcement supports the Illinois Commerce Commission's objective to establish "smart" as the new standard for all streetlights that ComEd owns in northern Illinois. ComEd will take advantage of the solution to reduce the cost of managing and maintaining the lights and to enhance the quality of service, reliability for community members through remote brightening and dimming features.

08:44 EDT Capstone Turbine secures order for C200 in Italy - Capstone Turbine announced that is has secured an order for a C200 from Capstone's distributor in Italy, Fores Engineering. The system will be installed on an unmanned offshore production platform in the North Sea. The C200 microturbine will ship with specifically designed packaging making it capable of withstanding the harsh elements expected on an unmanned offshore platform. The Capstone system will provide prime power for the entire platform. Looking for a solution that would tolerate gas quality fluctuations and meet the rigorous emissions regulations in the region, the operator turned to Capstone's regional oil and gas distributor for a reliable, low emission solution. Located in the Southern North Sea offshore from the United Kingdom, Tolmount is the largest gas prospect for the area in recent years. The greater Tolmount reserves are estimated to contain up to one trillion cubic feet of gas with first gas extraction targeted in 2020. The field is expected to produce gas for 10-15 years.

08:40 EDT OptimizeRx announces new parnterhsip with IllumiCare - OptimizeRx announced a new partnership with IllumiCare, a point-of-care healthcare information technology company. IllumiCare's smart ribbon platform will feature a new app from OptimizeRx, the RxSavings App, to present drug savings opportunities-such as co-pay offers and vouchers-that providers and the clinical care team can distribute to the patient directly at the point-of-care. The RxSavings App launch is set for Q2. IllumiCare is EHR-agnostic and has integrations with Epic, Cerner, Allscripts, Meditech and others. Known for providing cost and risk data to physicians directly at the point-of-care, the Smart Ribbon is customizable to hospital's needs. The technology is live across more than 120 hospitals in the United States.

08:38 EDT HCA Healthcare increases quarterly dividend to 40c per share - HCA announced that its Board of Directors declared a quarterly cash dividend of 40c per share on the Company's common stock. The dividend will be paid on March 29, 2019 to stockholders of record at the close of business on March 1, 2019.

08:37 EDT HCA Healthcare authorizes additional $2B share repurchase program - The HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $2B of the Company's outstanding common stock. Repurchases will be made in accordance with applicable securities laws and may be made at management's discretion from time to time in the open market, through privately negotiated transactions, or otherwise. The repurchase program has no time limit and may be suspended for periods or discontinued at any time.

08:33 EDT Kandi JV company signs cooperation agreement with Youxing Technology - Kandi Technologies Group announced that Kandi Electric Vehicles Group Co., Ltd., an equally held joint venture by Kandi Vehicles and Geely Group, Ltd., and Hangzhou Youxing Technology Co. have agreed to collaborate in exploring new and innovative models for an online ride-sharing business with their combined resources and market advantages. On January 28, 2019, representatives from each party, Zhu Feng, CEO of the JV Company and Dong Kainan, General Manager of Youxing Technology signed a Cooperation Agreement. Hu Xiaoming, Chairman of the JV Company and Liu Jinliang, Chairman of Youxing Technology also attended the signing ceremony. The two parties have agreed to utilize the "Cao Cao Zhuan Che" online ride-sharing platform to launch 20,000 Kandi brand pure electric vehicles for urban network ride-sharing services within three years.

08:32 EDT Fusion wins two major enterprise agreements - Fusion announced that it has secured two significant agreements to provide Fusion's application-aware cloud access and managed network services to one of the United States' largest financial companies based in the South and West, and to a leading restaurant chain located in the western United States. Fusion anticipates the expansion of these contracts to include Fusion's award-wining SD-WAN and cloud communications solutions, with total contract value expected to reach more than $5.4M over three years.

08:21 EDT Digital Ally announces update in Axon litigation - Digital Ally (DGLY) announced a development in its legal battle against Axon (AAXN). The U.S District Court for the District of Kansas issued the pretrial order in Digital Ally's litigation against Axon. The pretrial order details each party's theories and defines the scope of the case that will be presented to the jury after the Court deals with each party's expected summary judgment motion. As noted in the pretrial order, Digital is asserting that Axon has infringed, and is infringing, claims 10, 14, 15, 16, and 20 of the '452 Patent by making cameras that are compatible with the auto-activation technology in the axon signal unit, or ASU. The pretrial order also notes that Digital Ally believes Axon will be unable to meet its high burden of establishing invalidity and inequitable conduct, not least because Axon failed in its previous attempts with the U.S. Patent Office to invalidate the '452 Patent. The pretrial Order further notes that Digital Ally is seeking "reasonable royalty damages ... as a result of TASER's infringement of the '452 Patent from February 2, 2016 through August 17, 2018 [of] $68,456,524" and that "[p]rior to trial in this matter, Digital Ally will supplement its damages calculations." Digital Ally's damages calculations apply the royalty to "TASER's accused ASUs, Axon Signal-compatible cameras and their associated docks, and related purchases of Evidence.com." Because Digital Ally has alleged that Axon's infringement is willful, it also will be seeking to have any damages award trebled-a legal doctrine that, if successful, permits the court to triple the damages awarded by a jury. Finally, and of particular importance for the body-worn camera marketplace, Digital Ally is seeking a permanent injunction that will seek to remove from the marketplace Axon's auto-activation products, including the ASU as well as the Axon body and fleet cameras. Axon argues that any awarded damages should be "no more than 500,000" and should be limited to "ASU sales only."

08:13 EDT Lockheed Martin sees FY19 segment operating profit $6B-$6.15B - FY18 sales by segment is expected to be: $22.75B-$23.25B in Aeronautics, $9.7B-$10B in Space, $14.125B-$14.525B in RMS and $9.175B-$9.475B in MFC. Expects FY18 segment operating profit by segment: $2.44B-$2.49B in Aeronautics, $935M-$965M in Space, $1.29B-$1.33B in RMS and $1.335B-$1.365B in MFC. Sees net FAS/CAS pension adjustment approximately $1.47B. Guidance provided in conference call slides to be presented on Q4 earnings conference call.

08:10 EDT Agenus, Atomic Capital announce launch of digital securities offering - Atomic Capital and Agenus announced the launch of a groundbreaking digital securities offering enabling the direct participation of accredited investors in Agenus' lead immuno-oncology asset. The proceeds from the digital securities offering, the first conducted by a publicly-traded company, will go to fund product development through FDA approval and commercialization, of the asset, with returns to investors backed by future product sales.

08:09 EDT Great Panther Silver announces updates MRE for Topia Mine in Mexico - Great Panther Silver announces that it has completed an updated Mineral Resource Estimate, or MRE, in accordance with National Instrument 43-101 for the Company's 100% owned Topia silver-gold-lead-zinc Mine in Durango, Mexico. Highlights of the updated MRE include: Measured and Indicated Mineral Resources increased by 28% over the four-year period since the previous MRE in 2014, to 475.9 kt grading 461 g/t silver, 1.35 g/t gold, 3.87% lead and 4.06% zinc containing 14,770,000 silver equivalent ounces. Inferred Mineral Resources decreased by 3% over the same period, to 400.4 kt grading 434 g/t silver, 1.34 g/t gold, 2.86% lead, and 2.97% zinc, containing 10,720,000 Ag eq oz. Production since the MRE with effective date of November 30, 2014 totaled 221.6 kt, with average grades of 357 g/t silver, 0.67 g/t gold, 2.27% lead, and 3.03% zinc, containing 4,840,000 Ag eq oz. "We are very pleased to announce a 28% increase in the Measured and Indicated Mineral Resources at the Topia Mine to nearly 15M silver equivalent ounces," stated the company.

08:08 EDT Momenta reports first subject dosed in Phase 1/2 trial of M254 - Momenta Pharmaceuticals announced the dosing of the first subject in the Phase 1/2 clinical trial of M254, hypersialylated Immunoglobulin G. The Phase 1/2 study will enroll normal healthy volunteers and patients with Immune Thrombocytopenic Purpura. The multi-part study includes single and multiple dose parts, and a placebo-controlled, randomized double-blinded cross-over study comparing M254 to IVIg. The four part study will evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of intravenous M254 in approximately 65 subjects, including healthy volunteers and patients with ITP. Parts A and B are double-blind, placebo-controlled, single ascending dose cohort studies in healthy volunteers and ITP patients, respectively. In Part C, ITP patients will receive M254 or IVIg in a cross-over dosing design, while in Part D, ITP patients will receive multiple doses of M254. The primary efficacy endpoint is an assessment of platelet response.

08:06 EDT Luokung Technology and Beidou announce strategic partnership - Luokung Technology announced its strategic partnership with Beidou Navigation and Location Service, which is the builder and operator of Beidou Navigation and Location Service Industrial Public Platform. The partnership aims at providing a leading spatial-temporal big data platform service in the area of intelligent transportation to the Company's users. Both parties will promote the application of Beidou.

08:04 EDT GameStop: Evaluating 'optimal' use of Spring Mobile proceeds

08:04 EDT GameStop: Sale process terminated due to lack of available financing

08:04 EDT GameStop board continuing search process to appoint permanent CEO

08:02 EDT Flir Systems receives delivery order of $27.9M from DOD - FLIR Systems announced it has received a delivery order for 24 U.S. Army Chemical, Biological, Radiological, and Nuclear Dismounted Reconnaissance Sets, Kits, and Outfits, or CBRN DR-SKO, systems. The delivery order is under a five-year indefinite delivery, indefinite quantity, or IDIQ, contract from the U.S. Department of Defense, in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, or JPEO-CBRND, DR-SKO Program of Record. The order is valued at $27.9M, with deliveries extending through the third quarter of 2019.

07:51 EDT Ensco says Rowan Companies agreement raises annual expense synergies to $165M - Ensco (ESV) announced that the Company has entered into an amendment to the transaction agreement with Rowan Companies (RDC) under which the companies will combine in an all-stock transaction. The amendment has been unanimously approved by each company's board of directors. Under the terms of the amended transaction agreement, Rowan shareholders will receive 2.750 Ensco shares for each Rowan share and upon closing, Ensco and Rowan shareholders would own approximately 55% and 45%, respectively, of the outstanding shares of the combined company. All other terms and conditions of the transaction agreement that Ensco and Rowan entered into on October 7, 2018 remain the same. Odey Asset Management LLP, one of Rowan's largest shareholders as of the most recent regulatory filings, has pledged its support for the amended transaction by entering into an irrevocable voting agreement for the firm's holdings of approximately 11.4 million Rowan shares, or approximately 9% of Rowan's shares outstanding. Following months of integration planning, Ensco and Rowan now expect to realize annual pre-tax expense synergies of approximately $165M, which represents a 10% increase from the annual pre-tax expense synergies contemplated at the time of announcement of the transaction in October 2018. Further, more than 75% of targeted synergies are expected to be realized within one year of closing. The combined company expects to capitalize on an expanded, high-quality fleet serving a larger customer base across a wider geographic footprint, resulting in significant future revenue growth opportunities. Estimated annual expense synergies of $165M are expected to create approximately $1.1B of capitalized value for shareholders. Based on these anticipated annual savings, the transaction is expected to be accretive to cash flow per share annually for the combined entity beginning in 2020. The combined company's balance sheet is expected to have liquidity of $3.7B, including $1.7B of cash and short-term investments, providing the pro forma entity with the financial flexibility to continue investing in the fleet and innovations aimed at improving drilling efficiencies. The combined company's credit profile will benefit from increased scale and significantly enhanced diversification across regions, rig types, customers and expertise due to the diverse makeup of Ensco and Rowan's businesses. The combined company's total contracted revenue backlog would be approximately $2.6B.

07:46 EDT Rowan Companies amends transaction agreement with Ensco - Rowan Companies (RDC) announced that it has entered into an amendment to the Transaction Agreement with Ensco (ESV) providing for the combination of the two companies in an all-stock transaction. Under the amended agreement, Rowan shareholders will receive 2.750 shares of Ensco for each share of Rowan they own. All other terms and conditions of the agreement entered into on October 7, 2018, remain the same. Several Rowan shareholders have indicated their support for the transaction and the value creation opportunity that the pending combination presents to the Company's shareholders. In concert with the amended transaction agreement, Odey Asset Management LLP, one of Rowan's largest shareholders as of the most recent regulatory filings, has pledged its support to Ensco by entering into an irrevocable voting agreement for the firm's holdings of approximately 11.4 million Rowan shares, or approximately 9% of Rowan's shares outstanding.

07:36 EDT Neovasc completes Phase 1 requirements of TIARA-II study - Neovasc announced that it has completed the Phase 1 requirements of the TIARA-II study required by the bi-phasic study design in both Germany and the United Kingdom and has received approval to proceed with Phase 2 of the TIARA-II study for its Tiara transcatheter mitral valve replacement device. This approval comes following Clinical Events Committee adjudication of adverse events, Data and Safety Monitoring Board review of the data, and Governmental regulatory and ethics committees reviews of the interim clinical report provided for 20 implanted subjects. This approval will allow the TIARA-II study to proceed in these geographies with no restrictions. The TIARA-II study is an international, multicenter, single-arm, prospective, non-randomized, safety and performance clinical study. The total enrollment goal for the study in all geographies is 115 implanted subjects.

07:34 EDT Lockheed Martin CEO says 'well-positioned for continued growth' in 2019 - "The corporation completed another year of outstanding operational accomplishments and strong financial performance," said Lockheed Martin Chairman, President and CEO Marillyn Hewson. "As we look ahead to 2019, we remain focused on performing with excellence for customers, and our record backlog and differentiating portfolio have us well-positioned for continued growth and long-term value creation for shareholders."

07:33 EDT KemPharm announces continued enhancements to intellectual property - KemPharm announced continued enhancements to its U.S. and global intellectual property estate governing its portfolio of prodrug product candidates. The United States Patent and Trademark Office, or USPTO, issued seven new patents to KemPharm during 2018 related to several of its compound families, including KP201, KP303, KP511, KP606 and KP746. In addition, KemPharm has augmented and strengthened the global patent estate for KP415 with the addition of issued patents last year in Canada, Japan and Korea.

07:17 EDT OncoCyte: DetermaVu showed 90% sensitivity in R&D Validation study - OncoCyte Corporation announced results from its key R&D Validation study demonstrating the accuracy of the company's DetermaVu liquid biopsy test for lung cancer. The R&D Validation study demonstrated a sensitivity of 90% and specificity of 75% of DetermaVu on a prospectively collected cohort of 250 patient blood samples that were blinded to laboratory operators. Sensitivity is the percentage of malignant nodules that are correctly identified and specificity is the percentage of benign nodules correctly identified. A 95% confidence interval suggests that there is a 95% chance that final test performance will be within the stated range. These results show that DetermaVu significantly exceeds the critical parameters necessary for use in lung cancer diagnosis and that DetermaVu clearly outperforms reported results from competitors' tests and other clinical models. Based on this strong performance, OncoCyte believes that DetermaVu is the best-in-class lung cancer liquid biopsy diagnostic test. OncoCyte plans to make DetermaVu commercially available in the second half of 2019, with the goal of fundamentally changing the way lung cancer is diagnosed.

07:15 EDT Biogen CEO says made 'significant progress' developing pipeline in 2018 - "In 2018 Biogen executed well against our strategic priorities and financial objectives," said Michel Vounatsos, Biogen's CEO. "We made significant progress developing and expanding our pipeline, as well as advancing multiple modalities to potentially deliver new therapies to patients. We also reported solid revenue growth for the year, led by continued strong global penetration of SPINRAZA, significant gains in our biosimilars business, and resilience in our core MS business. We believe our strong base business, including a deep and diversified neuroscience pipeline, positions Biogen well to take advantage of the opportunities before us. As always, we remain focused on allocating capital efficiently and appropriately with the objective of maximizing returns for our shareholders over the long term."

07:10 EDT Visa, NFL extend partnership ahead of Super Bowl LIII - Visa, a partner of the National Football League since 1995, announced a renewed agreement with the NFL to serve as the league's Official Payment Services Technology Partner through the 2025 season. The new multi-year sponsorship deal includes new benefits for Visa cardholders at NFL events and plans to collaborate on the first cashless Super Bowl in the future. The partnership news comes days before the leader in digital payments brings contactless and cashless payment experiences to Super Bowl LIII fans in Atlanta.

07:07 EDT Allergan CEO says 'confident' in producing 'solid results' in 2019 - "Allergan posted another quarter of strong results to close out 2018, underscoring our focus on execution, financial discipline and the strength of our core business which grew 8.3%. Our anchor brands BOTOX Cosmetic, BOTOX Therapeutic, VRAYLAR, JUVEDERM, Lo LOESTRIN, CoolSculpting and LINZESS added nearly $1 billion in new revenue to our core business in 2018," said Brent Saunders, Chairman and CEO of Allergan. "I'm also proud of the significant advances we have made in our R&D pipeline with positive clinical results reported from six late-stage development programs. We look to build on that progress in 2019. Taken together, these accomplishments and our talented colleagues give me confidence in our ability to continue producing solid results in 2019 and beyond, while also delivering innovation that will have an enduring impact on patients, customers and shareholders."

07:06 EDT Allergan sees FY19 adjusted gross margin 85.0%-85.5% - Sees FY19 adjusted tax rate 13.0%-13.5%.

07:03 EDT Neurocrine, Voyager Therapeutics form development, commercialization agreement - Neurocrine Biosciences, Inc. (NBIX) and Voyager Therapeutics, Inc. (VYGR) announced the formation of a strategic collaboration focused on the development and commercialization of Voyager's gene therapy programs, VY-AADC for Parkinson's disease and VY-FXN01 for Friedreich's ataxia, as well as rights to two programs to be determined. This collaboration combines Neurocrine Biosciences' expertise in neuroscience, drug development and commercialization with Voyager's innovative gene therapy programs targeting severe neurological diseases. Under the terms of the agreement, Neurocrine Biosciences has agreed to pay Voyager $165 million in cash including a $115 million upfront payment and a $50 million equity investment at a Voyager per share price of $11.96. Voyager will also receive funding from Neurocrine Biosciences for all costs incurred on these collaboration programs as described below. In addition, Voyager may be entitled to earn up to $1.7 billion in development, regulatory and commercial milestone payments across the four programs. Under terms of the agreement for VY-AADC for Parkinson's disease:Neurocrine Biosciences has agreed to fund the clinical development of the Phase 2-3 pivotal program for VY-AADC. After the data readout of the Phase 2 RESTORE-1 trial, Voyager has the option to either: (1) co-commercialize VY-AADC with Neurocrine Biosciences in the U.S. under a 50/50 cost- and profit-sharing arrangement and receive milestones and royalties based on ex-U.S. sales, or (2) grant Neurocrine Biosciences full global commercial rights in exchange for milestone payments and royalties based on global sales. Under terms of the agreement for VY-FXN01 for Friedreich's ataxia: Neurocrine Biosciences has agreed to fund the development through the Phase 1 clinical trial of VY-FXN01. After the data readout of the Phase 1 trial, Voyager has the option to either: (1) co-commercialize VY-FXN01 with Neurocrine Biosciences in the U.S. under a 60/40 cost- and profit-sharing arrangement, or (2) grant Neurocrine Biosciences full U.S. commercial rights in exchange for milestone payments and royalties based on U.S. sales. Sanofi Genzyme retains an option for ex-U.S. rights to VY-FXN01 following the data readout of the Phase 1 trial. Under terms of the agreement for the two programs to be determined: Neurocrine Biosciences has agreed to fund the development of these programs to be determined and Voyager will have the right to earn milestone payments and royalties based on global sales.

06:57 EDT Harley-Davidson reports FY18 cash flow from operations over $200M, up 20% - The company also reports FY18 "international retail motorcycle sales finished slightly ahead of 2017. U.S. retail sales fell 10.2% behind ongoing declines in the U.S. motorcycle industry. Worldwide retail sales decreased 6.1% in 2018."

06:54 EDT Harley-Davidson sees FY19 motorcycle shipments 217K-222K vs. 228.1K in FY18 - Sees FY19 motorcycles segment operating margin as a percent of revenue to be approximately 8.0% to 9.0%, financial cervices segment operating income to be down year-over-year, effective tax rate of approximately 24.0% to 25.0% and capital expenditures of $225M-$245M.

06:51 EDT Pfizer says sees FY19 quarterly dividend payments of 36c per share - Sees approximately $9B of share repurchases, of which $1.4B have been repurchased through January 29.

06:49 EDT Pfizer says anticipates 2019 share repurchases approximately $9B - Financial guidance for adjusted diluted EPS reflects anticipated share repurchases totaling approximately $9B in 2019. Dilution related to share-based employee compensation programs is currently expected to offset the reduction in shares associated with these share repurchases by approximately half.

06:47 EDT Pfizer sees 'essentially flat' operational performance in FY19 vs. FY18

06:40 EDT L3 Technologies sees FY19 operating margin 12% - Sees FY19 effective tax rate 20%.

06:38 EDT Anixter sees FY19 organic sales up 3%-6% - Anixter commented, "As we look ahead to 2019, we are optimistic that favorable sales trends will continue, based on our record backlog, strong pipeline trends, and ongoing discussions with our customers and suppliers. The demand environment remains solid, tempered by uncertainty caused by economic policies and geopolitical issues. Based on current conditions, we estimate 2019 organic sales growth in the 3%-6% range, with Q1 organic sales growth in the 3%-5% range. Based on our outlook for low-to-mid single digit sales growth and the related investment in working capital to support that growth, combined with our ongoing investment in innovation and business transformation, we estimate cash flow from operations of $150M-$175M and capital investment of $55M-$60M. As we turn to 2019, we are focused on the significant opportunity to leverage our unique set of products and innovative solutions across our global network."

06:37 EDT Xerox sees FY19 operating cash flow $1.15B-$1.25B - Sees FY19 free cash flow $1B-$1.1B.

06:37 EDT Pfizer, Eli Lilly: Tanezumab 5mg met all 3 co-primary endpoints in Phase 3 study - Pfizer (PFE) and Eli Lilly and Company (LLY) announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg or 5 mg in patients with moderate-to-severe osteoarthritis pain. The tanezumab 5 mg treatment arm met all three co-primary endpoints at 24 weeks, demonstrating a statistically significant improvement in pain, physical function and the patients' overall assessment of their OA compared to those receiving placebo. The tanezumab 2.5 mg treatment arm met two of the three protocol-defined co-primary efficacy endpoints compared to placebo, demonstrating a statistically significant improvement in pain and physical function, while patients' overall assessment of their OA was not statistically different than placebo. Tanezumab is a humanized monoclonal antibody that is part of an investigational class of non-opioid pain medications known as nerve growth factor inhibitors. In this study, subcutaneous administration of tanezumab 2.5 mg or 5 mg was evaluated every eight weeks, for a total of 24 weeks, in patients with moderate-to-severe OA pain. Patients enrolled in the study had experienced inadequate pain relief from or intolerance to at least three different classes of analgesics, and on average had OA for more than six years. They also reported significant impact of their pain on their ability to function in everyday life. Preliminary safety data showed that tanezumab was generally well tolerated during the 24-week treatment period, with similarly low rates of treatment discontinuations due to adverse events observed among patients taking tanezumab and placebo. The trial also included a 24-week safety follow-up period, for a total of 48 weeks of observation.

06:32 EDT PulteGroup reports FY18 backlog of 8,722 Homes Valued at $3.8B

06:32 EDT Xerox approves incremental share repurchase authority of $1B - Company expects at least $300M of share repurchases in 2019.

06:13 EDT Polaris Industries reports Q4 dealer inventory up 1% year-over-year - In line with expectations.

06:13 EDT Polaris Industries sees positive adjusted FY19 EPS growth - The full year earnings guidance is inclusive of the company's expectations related to the impact of external factors such as the annualized impact of current tariffs which assumes 301, list 3 remains at the current 10% rate for the full year, adverse foreign exchange impacts, and higher interest rates, totaling approximately $1.50 per diluted share, on a combined basis. Absent these items, the company is expected to generate positive earnings growth on a year-over-year basis.

06:02 EDT Polaris Industries CEO says 'encouraged by our growth prospects for 2019' - Scott Wine, Chairman and CEO said, "Our strong performance during 2018 demonstrated the dedication and flexibility of our global team, as they drove improved financial and operating results for the year while adapting and executing our strategy to account for tariffs and other external pressures. Between sales growth in almost all of our segments, improved operational efficiencies, and a lower tax rate, we more than offset macro-economic and tariff headwinds, generating a 29 percent increase in earnings per share. Growth and market share gains in Off Road Vehicles, and the acquisition of Boat Holdings, further expanded our position as the global leader in Powersports, and established Polaris as a leader in the attractive, profitable and growing pontoon market. We are encouraged by our growth prospects for 2019 and beyond, but keenly aware of, and prepared for, the challenges and uncertainties presented by global trade and economic complications. We our doubling down on our commitment to be a customer-centric, highly efficient growth company, directing our investments and actions towards organic growth and productivity. Our devotion to safety and quality is never-ending, and provides the solid foundation for our future of innovation and profitable growth. We expect to demonstrate that in the year ahead with further market share gains in both ORV and motorcycles, as we continue to advance our leadership position in Powersports."

05:42 EDT PG&E holder BlueMountain calls Chapter 11 filing 'reckless' - BlueMountain Capital Management is deeply disappointed that the board of PG&E has ignored calls from multiple parties to abandon its reckless and irresponsible plan to file for bankruptcy -- a move that will harm all stakeholders. Today's filing is the latest example of how the board continues to fail the Company, wildfire victims, customers, employees, creditors, shareholders and the people of California. We urge all stakeholders to support change at PG&E and will be proposing a "New Slate" of highly-qualified and impartial directors. BlueMountain believes a new board is in the best interest of all PG&E stakeholders. Bankruptcy does not eliminate shareholders' corporate governance rights, including, among other things, their ability to nominate and elect directors at annual meetings. We plan to announce a proposed "New Slate" no later than February 21, 2019.

05:18 EDT CNOOC announces new discover in UK North Sea - CNOOC announced a new discovery on the Glengorm prospect, located in offshore UK Central North Sea. The Glengorm discovery is located in License P2215 with a water depth of approximately 86 meters. The exploration well Glengorm was drilled to a total depth of 5,056 meters and encountered net gas and condensate pay zones with a total thickness of 37.6 meters.

05:13 EDT PG&E files for Chapter 11, seeks court approval to access $5.5B in DIP - PG&E and its primary operating subsidiary, Pacific Gas and Electric Company, filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Northern District of California. Throughout the forthcoming process, PG&E remains committed to: Delivering safe and reliable electric and natural gas service to customers; Continuing to make critical investments in system safety and maintenance; Supporting the orderly, fair and expeditious resolution of its liabilities resulting from the 2017 and 2018 wildfires; Working with customers, civic leaders, regulators, policymakers, the financial community and other key stakeholders to consider alternatives to provide for the safe delivery of natural gas and electricity and new safety solutions in an environment challenged by climate change; and Assisting our customers and communities impacted by wildfires in Northern California. PG&E's restoration and rebuilding efforts will continue. "Our most important responsibility is and must be safety, and that remains our focus. Throughout this process, we are fully committed to enhancing our wildfire safety efforts, as well as helping restoration and rebuilding efforts across the communities impacted by the devastating Northern California wildfires. We also intend to work together with our customers, employees and other stakeholders to create a more sustainable foundation for the delivery of safe, reliable and affordable service in the years ahead. To be clear, we have heard the calls for change and we are determined to take action throughout this process to build the energy system our customers want and deserve," said John Simon, PG&E Corporation Interim CEO. In conjunction with the filings, PG&E also filed a motion seeking interim and final approval of the Court to enter into an agreement for $5.5B in debtor-in-possession, or DIP, financing with J.P. Morgan, Bank of America, Barclays, Citi, BNP Paribas, Credit Suisse, Goldman Sachs, MUFG Union Bank and Wells Fargo acting as joint lead arrangers. PG&E expects the Court to act on an interim basis on the DIP motion in the coming days. The DIP financing, when approved, will provide PG&E with necessary capital to ensure essential maintenance and continued investments in safety and reliability for the expected duration of the Chapter 11 cases. "Through this process, we will prioritize what matters most to our customers and the communities we serve - safety and reliability. We believe that this process will make sure that we have sufficient liquidity to serve our customers and support our operations and obligations," Simon said. "I know that our 24,000 dedicated employees remain steadfastly focused on delivering safe and reliable natural gas and electric service for the 16M people across our service area," said Simon. "Each day I see the hard work and resilience of our team, and I thank them for their continued dedication to working safely and delivering for our customers."